Alzheimer's genetic secrets offer hopes of drug cure: Neuroscientists are sorting out the complex mechanisms that cause the degenerative brain disease which affects half a million people in Britain. Ruth McKernan reports

Scientists are closing in on the mechanisms that underlie Alzheimer's disease, making it increasingly likely that drugs could soon be developed to combat the illness. An international conference in London last month on developments in the fight against Alzheimer's heard that scientists were confident of sorting out the fundamental mechanisms that give rise to the disease.

'Lots of things that once looked separate can now be brought into the same idea,' says Gareth Roberts, head of molecular neuropathology at the pharmaceutical company SmithKline Beecham.

More than half a million people in the UK suffer from Alzheimer's disease, a degenerative disorder in which brain cells slowly disintegrate, leaving the shrunken organ littered with plaques (large sticky clumps of aggregated protein) and tangles (scrambled filaments that once formed the framework of cells).

Since the turn of the century, pathologists have been approaching Alzheimer's by investigating changes in the brains of victims. They have catalogued the consequences but have been unable to find the cause. Clues have come instead from modern genetic studies.

A few years ago, John Hardy, then at St Mary's Hospital, London, studied a family in which all members suffered from the disease at an early age. He found its members shared a mutant gene. This gene normally controls the synthesis of amyloid precursor protein (APP), which is broken down inside brain cells to form a smaller unit, beta-amyloid, the major component of the sticky plaques that clog the brain. Those with a defective gene metabolise APP abnormally.

For the dozen or so families with a mutant gene, the link between APP and Alzheimer's is beyond dispute. For the rest, the APP gene is normal, and the cause of the cerebral deterioration remains unknown. None the less, some scientists believe that the genetic studies point to amyloid as the root of the problem for most, if not all, victims.

'Alzheimer's could be regarded as a disease of amyloid metabolism in the same way that heart disease is a disease of cholesterol metabolism. It is probably one disease with multiple causes,' Dr Hardy says.

As neuroscientists try to understand Alzheimer's by studying APP and how it changes in the disease, Allen Roses, professor of neurology at Duke University, North Carolina, has approached the problem from a different direction.

Last year he identified a second gene that influences the age at which a person develops Alzheimer's. The gene has no mutations and appears to have little to do with amyloid plaques or tangles. It controls the synthesis of a molecule (apolipoprotein E, ApoE) that transports fats in the body and comes in three forms, ApoE2, ApoE3 and ApoE4. Humans have two copies of the gene, one from each parent, which need not be the same.

Professor Roses and his colleagues found a strong link between the type of ApoE and the age at which Alzheimer's is likely to develop. People with two copies of ApoE4 will develop the disease, on average, at age 68; those with one copy each of ApoE3 and ApoE2 will be free of the illness, on average, until they are more than 90.

This link has been confirmed in other laboratories, and the abundance of ApoE4 in a population is related to the incidence of Alzheimer's. ApoE4 is less common in Japanese people, for example, and as a nation they develop Alzheimer's later than Europeans. The protective effect of ApoE2 is highlighted in a paper by Professor Roses and his colleagues in this month's Nature Genetics.

The difference between the three forms of ApoE is minuscule but can greatly affect the age at which mental faculties decline. 'A single amino acid change in a protein can determine two decades of difference in onset of the disease,' Professor Roses says. ApoE seems to be important in the progression and development of Alzheimer's but may not start it. Dr Roberts believes that Alzheimer's develops as a consequence of programmed changes in the brain.

'After the age of 20 we start losing about 1,000 nerve cells a day,' he says. 'By the age of 50, nerve cells automatically start resprouting.' This is the equivalent of a forest losing trees but the remaining ones gaining extra branches to compensate. For brain cells to repair and extend they need supplements of many construction materials. Fats, one of the essential building blocks of cell membranes, are ferried to the needy nerves by ApoE. Unlike other cells in the body, brain cells are not renewed or replaced. A 60-year-old cell suddenly having to increase its metabolic effort is like a senior citizen taking up jogging; the strain can prove too much.

The details of which parts of the machinery give out first have yet to be decided. Dr Hardy's corner believes that molecules such as ApoE and amyloid, which would normally be broken down and cleared away, begin to accumulate and stick to each other or to other structural cell components. Over a long time the slow accumulation of biochemical debris clogs up cell terminals, prevents them functioning and ultimately kills them, leaving only plaques or tangles behind. Professor Roses regards the deposition of amyloid as a consequence rather than a cause. More information will be needed before the picture is complete.

Athena Neurosciences, a diagnostics company in San Francisco, is developing a kit to test which forms of ApoE an individual carries. While two copies of ApoE4 would not be comforting news, the results do not predict who will get the disease but, rather, what a person's susceptibility might be. Scientists anticipate that the information could show how an individual's genetic profile controls the progress of the disease. Since Alzheimer's is regulated by many factors, this kind of test could help to predict potential treatments.

It is still ear1y days in the development of treatments. Current drugs aim only to compensate for missing chemicals rather than alter the course of the disease. But experts believe that now more is known about the biochemistry involved, more effective drugs could be developed - and they are not short of ideas.

'We could try to block production of APP, or prevent it being broken down to beta-amyloid,' Dr Roberts says. 'If we could prevent the interaction between APP and ApoE, that might slow the disease, too. Technically, some of these things might be a challenge, but for something as important as Alzheimer's disease, we have to try.'

Professor Roses is collaborating with Glaxo to set up new test-tube screening procedures, searching for drugs that interfere with the reactions of ApoE2, ApoE3 and APoE4. He believes an effective drug will be available before the end of the century. With most drugs taking at least 10 years from lab to prescription pad, this could be optimistic. 'Some researchers get very upset about giving people false hope, but when a drug company invests the money to start screening we believe there is some hope,' he says.

(Photograph omitted)

PROMOTED VIDEO
News
REX/Eye Candy
science
News
A photo of Charles Belk being detained by police on Friday 22 August
news
News
i100
Sport
Alexis Sanchez celebrates after scoring his first goal for Arsenal in the Champions League qualifier against Besiktas
sportChilean's first goal for the club secures place in draw for Champions League group stages
Arts and Entertainment
Amis: 'The racial situation in the US is as bad as it’s been since the Civil War'
booksAuthor says he might come back across Atlantic after all
Extras
indybest
News
ebooksAn evocation of the conflict through the eyes of those who lived through it
Life and Style
Google Doodle celebrates the 200th birthday of Irish writer Sheridan Le Fanu
tech
Arts and Entertainment
Vinyl demand: a factory making the old-style discs
musicManufacturers are struggling to keep up with the resurgence in vinyl
News
i100
News
In Eternal Sunshine of the Spotless Mind Jim Carrey and Kate Winslett medically erase each other from their memories
scienceTechnique successfully used to ‘reverse’ bad memories in rodents could be used on trauma victims
Arts and Entertainment
Singer Pixie Lott will take part in Strictly Come Dancing 2014, the BBC has confirmed
tv
Independent
Travel Shop
the manor
Up to 70% off luxury travel
on city breaks Find out more
santorini
Up to 70% off luxury travel
on chic beach resorts Find out more
sardina foodie
Up to 70% off luxury travel
on country retreats Find out more
Latest stories from i100
Have you tried new the Independent Digital Edition apps?
Independent Dating
and  

By clicking 'Search' you
are agreeing to our
Terms of Use.

iJobs Job Widget
iJobs General

C# Developer (C#, ASP.NET Developer, SQL, MVC, WPF, Real-Time F

£40000 - £48000 per annum + benefits+bonus+package: Harrington Starr: C# Devel...

C# Swift Payment Developer (C#, ASP.NET, .NET, MVC, Authorize.N

£45000 - £60000 per annum + benefits+bonus+package: Harrington Starr: C# Swift...

Front-End Developer (JavaScript, HTML5, CSS3, C#, GUI)

£55000 - £70000 per annum + Benefits + Bonus: Harrington Starr: Front-End Deve...

Graduate C# Developer (.NET, WPF, SQL, Agile, C++) - London

£30000 - £40000 per annum + Benefits + Bonus: Harrington Starr: Graduate C# De...

Day In a Page

Israel-Gaza conflict: No victory for Israel despite weeks of death and devastation

Robert Fisk: No victory for Israel despite weeks of devastation

Palestinians have won: they are still in Gaza, and Hamas is still there
Mary Beard writes character reference for Twitter troll who called her a 'slut'

Unlikely friends: Mary Beard and the troll who called her a ‘filthy old slut’

The Cambridge University classicist even wrote the student a character reference
America’s new apartheid: Prosperous white districts are choosing to break away from black cities and go it alone

America’s new apartheid

Prosperous white districts are choosing to break away from black cities and go it alone
Amazon is buying Twitch for £600m - but why do people want to watch others playing Xbox?

What is the appeal of Twitch?

Amazon is buying the video-game-themed online streaming site for £600m - but why do people want to watch others playing Xbox?
Tip-tapping typewriters, ripe pongs and slides in the office: Bosses are inventing surprising ways of making us work harder

How bosses are making us work harder

As it is revealed that one newspaper office pumps out the sound of typewriters to increase productivity, Gillian Orr explores the other devices designed to motivate staff
Manufacturers are struggling to keep up with the resurgence in vinyl records

Hard pressed: Resurgence in vinyl records

As the resurgence in vinyl records continues, manufacturers and their outdated machinery are struggling to keep up with the demand
Tony Jordan: 'I turned down the chance to research Charles Dickens for a TV series nine times ... then I found a kindred spirit'

A tale of two writers

Offered the chance to research Charles Dickens for a TV series, Tony Jordan turned it down. Nine times. The man behind EastEnders and Life on Mars didn’t feel right for the job. Finally, he gave in - and found an unexpected kindred spirit
Could a later start to the school day be the most useful educational reform of all?

Should pupils get a lie in?

Doctors want a later start to the school day so that pupils can sleep later. Not because teenagers are lazy, explains Simon Usborne - it's all down to their circadian rhythms
Prepare for Jewish jokes – as Jewish comedians get their own festival

Prepare for Jewish jokes...

... as Jewish comedians get their own festival
SJ Watson: 'I still can't quite believe that Before I Go to Sleep started in my head'

A dream come true for SJ Watson

Watson was working part time in the NHS when his debut novel, Before I Go to Sleep, became a bestseller. Now it's a Hollywood movie, too. Here he recalls the whirlwind journey from children’s ward to A-list film set
10 best cycling bags for commuters

10 best cycling bags for commuters

Gear up for next week’s National Cycle to Work day with one of these practical backpacks and messenger bags
Paul Scholes: Three at the back isn’t working yet but given time I’m hopeful Louis van Gaal can rebuild Manchester United

Paul Scholes column

Three at the back isn’t working yet but given time I’m hopeful Louis van Gaal can rebuild Manchester United
Kate Bush, Hammersmith Apollo music review: A preamble, then a coup de théâtre - and suddenly the long wait felt worth it

Kate Bush shows a voice untroubled by time

A preamble, then a coup de théâtre - and suddenly the long wait felt worth it
Robot sheepdog technology could be used to save people from burning buildings

The science of herding is cracked

Mathematical model would allow robots to be programmed to control crowds and save people from burning buildings
Tyrant: Is the world ready for a Middle Eastern 'Dallas'?

This tyrant doesn’t rule

It’s billed as a Middle Eastern ‘Dallas’, so why does Fox’s new drama have a white British star?